Contributors. List of special reviews. How to use this book. Essay: Complementary/alternative medicine: what should we do about it? (E. Ernst). Central nervous system stimulants and drugs that suppress appetite (R.P. Sequeira). Antidepressant drug (P.J. Cowen). Lithium (M. Schou). Drugs of abuse (J.K. Patel et al.). Hypnotics and sedatives (S. Curran, W. Burn). Antipsychotic drugs (A. Carvajal, L.H. Martín Arias). Antiepileptic drugs (E. Perucca). Opioid analgesics and narcotic antagonists (A.H. Ghodse, R.E. Edwards). Anti-inflammatory and antipyretic analgesics and drugs used in gout (A. Del Favero). General anesthetics and therapeutic gases (J.K. Aronson). Local anesthetics (S. Schug, D. SideBotham). Neuromuscular blocking agents and skeletal muscle relaxants (M. Leuwer, O. Zuzan). Drugs affecting autonomic functions or the extrapyramidal system (M. Schachter). Dermatological drugs, topical agents, and cosmetics (A.C. de Groot). Antihistamines (L. Turner). Drugs acting on the respiratory tract (G. Boman). Positive inotropic drugs and drugs used in dysrhythmias (J.K. Aronson). &bgr;-Adrenoceptor antagonists and antianginal drugs (A.P. Maggioni et al.). Drugs acting on the cerebral and peripheral circulations (R. Verhaeghe). Antihypertensive drugs (F. Zannad). Diuretics (G.T. McInnes). Metals (G.B. van der Voet, F.A de Wolff). Metal antagonists (R.H.B. Meyboom). Antiseptic drugs and disinfectants (P. Magee). Penicillins, cephalosporins, other &bgr;-lactam antibiotics and tetracyclines (T. Midtvedt). Miscellaneous antibacterial drugs (S.H. Khoo, T. Walley). Antifungal drugs (J.K. Aronson). Antiprotozoal drugs (M. Pirmohamed, P.A. Winstanley). Antiviral drugs (P. Reiss, M.D. de Jong). Drugs used in tuberculosis and leprosy (M.J. Dedicoat, C.J. Ellis). Antihelminthic drugs (A.G.C. Bauer). Vaccines (S. Dittmann). Blood, blood components, plasma, and plasma products (H.W. Eijkhout, W.G. van Aken). Intra
The Side Effects of Drugs Annual has been published each year since 1977. It is designed to provide a critical and up-to-date account of new information related to adverse drug reactions and interactions from the clinician's point of view.
Under the supervision of the series editors, an international team of expert authors have gathered together the latest information on adverse drug effects from the international literature. In addition to describing new reports of adverse drug effects, the authors have subjected those reports to critical analysis, setting them into context in terms of clinical relevance and importance, and cross-referring to previous reports where necessary. New adverse effects are reported and evaluated and previously reported adverse effects are re-evaluated in the light of the most recent information. A special feature is the reviews, in which selected adverse effects are discussed in depth. The use of the book is enhanced by two separate indexes, allowing the reader to enter the text by drug name, adverse effect name, or drug interaction.
The Annual can be used independently or as a supplement to the standard encyclopaedic work in this field, Meyler's Side Effects of Drugs, of which, the http://www.elsevier.nl/locate/isbn/0444500936Fourteenth Edition was published in December 2000.
For clinical pharmacologists, pharmaceutics and toxicologists.
- © Elsevier Science 1997
- 17th December 1997
- Elsevier Science
- eBook ISBN:
- Hardcover ISBN:
@from:(G. Bianchi Porro, Milan, Italy) @qu:You will find a lot of useful, although frequently unexpected, information on practically all those drugs prescribed every day but which are normally either not considered at all or are believed to be of limited significance (which is often not true). The volume is especially designed for clinical pharmacologists, pharmaceutists and toxicologists. However, all physicians should know of its existence when consultation in the specific field is required. @source:Italian Journal Gastroenterol Hepatol, 31
Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK’s National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.
Department of Primary Health Care, University of Oxford, Oxford, UK